Ciprofloxacin BioThrax Co-Administration Study

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Anthrax
Interventions
BIOLOGICAL

BioThrax

route of administration/schedule- 0.5 mL subcutaneous (SC) injection / 0-2-4 week schedule

DRUG

Ciprofloxacin

500 mg twice a day (Days 1-6, 19-21, 33-35, 40-48).

Trial Locations (3)

64114

The Center for Pharmaceutical Research, Kansas City

68134

Meridian Clinical Research, Omaha

75234

Research Across America, Dallas

Sponsors
All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Emergent BioSolutions

INDUSTRY